| 1188 |
Centers for Disease Control and Prevention |
Html |
en |
Progress Toward Measles Elimination - Eastern MediterraneanRegion, 2008-2012 |
Nadia Teleb, MD1, Emmaculate Lebo, MBChB2, Hinda Ahmed, PhD1, Abdel Rahman Hossam1, El Tayeb El Sayed, MD1, Alya Dabbagh, PhD3, Peter Strebel, MBBS3, Paul Rota, PhD4, James Alexander, MD2 (Author affiliations at end of text). |
| measles vaccination schedules | 0.580376 |
| Gaza Strip | 0.38471 |
| 2-dose vaccination coverage | 0.411124 |
| measles elimination | 0.851315 |
| measles incidence | 0.634839 |
| vaccination coverage | 0.524842 |
| measles outbreaks | 0.551956 |
| MCV1 coverage | 0.469635 |
| measles mortality | 0.507656 |
| measles virus | 0.552036 |
| routine immunization services | 0.433595 |
| South Sudan | 0.485025 |
| endemic measles | 0.540827 |
| Rubella Laboratory Network | 0.451111 |
| measles susceptibility | 0.498152 |
| measles elimination activities | 0.544237 |
| measles virus isolation | 0.540906 |
| routine 2-dose coverage | 0.383157 |
| EMR measles cases | 0.618153 |
| nationwide measles | 0.520885 |
| emr measles | 0.619207 |
| measles case-based surveillance | 0.725839 |
| routine 2-dose vaccination | 0.406709 |
| vaccination services | 0.41302 |
| Global Measles | 0.532508 |
|
| surveillance performance indicators | 0.423733 |
| measles cases | 0.743783 |
| measles elimination goal | 0.595162 |
| routine vaccination services | 0.389238 |
| West Bank | 0.386474 |
| Large measles outbreaks | 0.548094 |
| Eastern Mediterranean Region | 0.417869 |
| MCV2 vaccination coverage | 0.39416 |
| measles vaccine | 0.522085 |
| Routine MCV1 coverage | 0.391307 |
| nationwide catch-up SIAs | 0.390458 |
| high incidence | 0.410542 |
| measles virus genotype | 0.539418 |
| administrative coverage | 0.403432 |
| endemic measles cases | 0.538272 |
| EMR countries | 0.770577 |
| national case-based surveillance | 0.395645 |
| case-based surveillance performance | 0.438015 |
| endemic measles transmission | 0.527958 |
| subsequent measles outbreaks | 0.53488 |
| follow-up sias | 0.413392 |
| follow-up SIAs target | 0.396233 |
| measles | 0.969846 |
| complete measles | 0.497807 |
|
CLICK HERE |
| 6363 |
Centers for Disease Control and Prevention |
Html |
en |
Halloween the Healthy Way |
Family health information from the Centers for Disease Control and Prevention (CDC) |
| great healthy snack | 0.639314 |
| Insufficient sleep | 0.42857 |
| best ways | 0.392319 |
| fluoride toothpaste | 0.458058 |
| long-lasting diseases | 0.410541 |
| yummy fruits | 0.417821 |
| Halloween season | 0.6587 |
| secondhand smoke exposure | 0.604709 |
| flu vaccine | 0.474593 |
| Halloween festivities fun | 0.944584 |
| sugary treats | 0.404556 |
|
| Safe Family | 0.363338 |
| sure costumes | 0.393392 |
| indoor spaces | 0.367658 |
| trick-or-treaters | 0.205086 |
| tobacco-free events | 0.395314 |
| best protection | 0.38818 |
| smoking | 0.2095 |
| flu season | 0.726814 |
| party guests | 0.423466 |
| Halloween parties | 0.570975 |
|
CLICK HERE |
| 7614 |
Centers for Disease Control and Prevention |
Html |
en |
Multistate Fungal Meningitis Outbreak - Interim Guidance for Treatment |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| mmwrq@cdc.gov. | 0.564873 |
| endorsement | 0.464443 |
| Human Services | 0.643663 |
| assistive technology | 0.567224 |
| MMWR HTML versions | 0.657324 |
| U.S. Department | 0.640442 |
| electronic PDF version | 0.644109 |
| brown-black mold | 0.590032 |
| potentially contaminated product | 0.790199 |
| possible fungal infections | 0.771168 |
| expert opinion | 0.53961 |
| Additional information | 0.543921 |
| Contact GPO | 0.566238 |
| intra-articular injections | 0.603814 |
| commercial sources | 0.540745 |
| current prices | 0.535924 |
| New England Compounding | 0.675567 |
| original paper copy | 0.638799 |
| steroid products | 0.703913 |
| original MMWR paper | 0.652073 |
| U.S. Government Printing | 0.643522 |
| multistate meningitis outbreak | 0.728306 |
| Drug Administration | 0.553252 |
| spinal area | 0.548143 |
|
| empiric antifungal therapy | 0.688724 |
| parameningeal infections | 0.604824 |
| MMWR readers | 0.547669 |
| character translation | 0.533452 |
| adult patients | 0.642288 |
| format errors | 0.535082 |
| Exserohilum rostratum | 0.562469 |
| septic arthritis | 0.541861 |
| steroid injection | 0.625629 |
| Aspergillus species | 0.570674 |
| subject line | 0.554388 |
| typeset documents | 0.541868 |
| trade names | 0.540848 |
| CDC interim guidance | 0.906949 |
| official text | 0.53173 |
| predominant pathogen | 0.559382 |
| local public health | 0.685796 |
| peripheral joint space | 0.675992 |
| non-CDC sites | 0.539627 |
| brown-black molds | 0.590025 |
| NECC | 0.546997 |
| steroid medication | 0.622976 |
| investigation | 0.473003 |
| electronic conversions | 0.531471 |
|
CLICK HERE |
| 8091 |
Centers for Disease Control and Prevention |
Html |
en |
Newsroom - CDC Advisory -CDC's Advisory Committee on Immunization Practices Meeting |
[Title] |
| Centers | 0.436978 |
| free vaccine | 0.704935 |
| RSVP attendance | 0.653078 |
| routine discussion | 0.620634 |
| navigation Skip | 0.84601 |
| Haemophilus influenzae | 0.688374 |
| pertussis | 0.458094 |
| Prevention | 0.436899 |
| Immunization Practices | 0.884896 |
| Advisory Committee | 0.817263 |
| Need | 0.442036 |
| Clifton Road NE | 0.837514 |
| Disease Control | 0.632154 |
| immune-compromising conditions | 0.606926 |
| ACIP meeting | 0.711477 |
| page options | 0.652594 |
| Atlanta | 0.468158 |
| influenza vaccine recommendations | 0.886746 |
| U.S. DEPARTMENT | 0.605738 |
| contact | 0.43299 |
|
| http://www.cdc.gov/vaccines/acip/index.html | 0.435784 |
| visit http://www.cdc.gov/about/resources/visitGuide.htm#direction | 0.621822 |
| flu season | 0.608423 |
| pneumococcal conjugate vaccine | 0.907985 |
| PCV13 | 0.433111 |
| list Skip | 0.850791 |
| Tom Harkin Global | 0.849025 |
| Children program | 0.602482 |
| Hib vaccine | 0.794048 |
| media activities | 0.605767 |
| agency updates | 0.612181 |
| pneumococcal infection | 0.613212 |
| agenda | 0.488295 |
| workgroup updates | 0.623555 |
| content Skip | 0.849086 |
| directions | 0.435944 |
| Auditorium | 0.452976 |
| HUMAN SERVICES | 0.605255 |
| information | 0.436311 |
|
CLICK HERE |
| 9761 |
Centers for Disease Control and Prevention |
Html |
en |
CDC | TB | LTBI - Appendix D |
Centers for Disease Control and Prevention, Division of Tuberculosis Elimination |
| list Skip | 0.811505 |
| future mobile app | 0.713682 |
| page options Skip | 0.981906 |
| fact sheets | 0.484879 |
| clinical information | 0.486223 |
| navigation Skip | 0.822507 |
|
| testing recommendations | 0.493634 |
| Latent TB Infection | 0.953286 |
| guidance | 0.339851 |
| Latent Tuberculosis Infection | 0.896099 |
| latent TB infection. | 0.88015 |
| messages | 0.328179 |
|
CLICK HERE |
| 9766 |
Centers for Disease Control and Prevention |
Html |
en |
Notes from the Field: Salmonella Typhimurium InfectionsAssociated with a Community College Microbiology Laboratory -Maine, 2013 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| mmwrq@cdc.gov. | 0.816427 |
| microbiology class | 0.834438 |
| stool specimens | 0.803905 |
| Human Services | 0.881236 |
| teaching level | 0.803372 |
| assistive technology | 0.813555 |
| low response rate | 0.880529 |
| site visit | 0.868569 |
| case interviews | 0.804432 |
| U.S. Department | 0.880936 |
| MMWR HTML versions | 0.876063 |
| Disease Control | 0.813104 |
| PFGE analysis | 0.808308 |
| electronic PDF version | 0.87573 |
| hospital laboratories | 0.804231 |
| Salmonella Typhimurium outbreak | 0.973174 |
| PFGE pattern | 0.805546 |
| e-mail survey | 0.811388 |
| microbiology laboratory course | 0.949178 |
| personal protective equipment | 0.87752 |
| Environmental Testing Laboratory | 0.931183 |
| Contact GPO | 0.808019 |
| Epidemiologic interviews | 0.8099 |
| clinical Salmonella | 0.844364 |
|
| original paper copy | 0.869466 |
| laboratory class | 0.922899 |
| Southern Maine | 0.805431 |
| Maine Center | 0.826739 |
| potential contamination hazards | 0.873321 |
| pulsed field gel | 0.891129 |
| original MMWR paper | 0.883047 |
| U.S. Government Printing | 0.876275 |
| PFGE results | 0.814932 |
| college laboratory | 0.842664 |
| Human Svcs | 0.909064 |
| community college | 0.908047 |
| Maine Dept | 0.886299 |
| wear gloves | 0.824329 |
| subject line | 0.813786 |
| clinical isolates | 0.825983 |
| laboratory practices survey | 0.926145 |
| biologic safety guidelines | 0.883915 |
| national outbreak investigation | 0.923438 |
| laboratory coats | 0.828436 |
| Salmonella culture | 0.831971 |
| common exposure | 0.810774 |
| laboratory practices | 0.976496 |
| teaching microbiology laboratories | 0.91995 |
|
CLICK HERE |
| 9940 |
Centers for Disease Control and Prevention |
Html |
en |
Health Disparities - Tribal Support |
CDC/ATSDR Tribal Support is the primary link between CDC, the Agency for Toxic Substance and Disease Registry (ATSDR), and tribal governments. CDC/ATSDR’s tribal support activities focus on fulfilling CDC's supportive role in ensuring that American Indian/Alaska Native (AI/AN) communities receive public health services that keep them safe and healthy. |
| Office | 0.201494 |
| Indian Country | 0.491756 |
| CDC | 0.420934 |
| HHS operating divisions | 0.881483 |
| United States | 0.737657 |
| Alaska Natives | 0.532645 |
| Human Services | 0.446873 |
| multimedia resources | 0.43658 |
| Health Equity | 0.464662 |
| minority populations | 0.805205 |
|
| tribal nations | 0.488562 |
| health disparities | 0.487393 |
| AI/AN populations | 0.549201 |
| Alaska Native Heritage | 0.695215 |
| campaign information | 0.420434 |
| minority health | 0.974409 |
| American Indian/Alaska Native | 0.821159 |
| National American Indian | 0.693281 |
| tribal organizations | 0.487465 |
|
CLICK HERE |
| 10278 |
Centers for Disease Control and Prevention |
Html |
en |
Before a Wildfire - Prepare Your Home |
The Centers for Disease Control and Prevention (CDC) provides information on how to stay safe and healthy before, during, and after a wildfire including avoiding health impacts from wildfire smoke and cleaning up safely. |
| areas | 0.522533 |
| office | 0.501515 |
| full-sized image | 0.945947 |
| wildfires | 0.67088 |
| landscaping | 0.547411 |
| steps | 0.539413 |
| people | 0.523212 |
| home | 0.74003 |
|
| Ready | 0.541313 |
| print | 0.502381 |
| wildfire | 0.991122 |
| homes | 0.522805 |
| risk | 0.509611 |
| Infographic | 0.501415 |
| family | 0.507414 |
|
CLICK HERE |
| 11626 |
Centers for Disease Control and Prevention |
Html |
null |
Appendix: Additional Results and Technical Notes for the EbolaResponse Modeling Tool |
Numbers of Ebola virus disease cases (hereafter referred to as Ebola) and daily number of beds in use in Liberia and Sierra Leone alone (Figure 1) and in Liberia and Sierra Leone combined (Figure 2) were estimated using the EbolaResponse modeling tool. The outcome of potential interventions on number of cases and beds in use in the two countries combined was simulated (Figure 3). |
|
|
CLICK HERE |
| 12875 |
Centers for Disease Control and Prevention |
Html |
en |
MMWR News Synopsis for February 26, 2015 |
MMWR – Morbidity and Mortality Weekly Report CDC public health news, press releases, government public health news, medical and disease news, story ideas, photos. |
| Deputy Director Communications | 0.40548 |
| Ebola treatment unit | 0.478265 |
| public health intervention | 0.420626 |
| effective community quarantine | 0.432523 |
| public health interventions | 0.415788 |
| pulmonary tuberculosis | 0.614604 |
| Effective prevention approaches | 0.38786 |
| U.S. emergency departments | 0.383005 |
| airborne infection isolation | 0.675762 |
| room staff members | 0.392836 |
| infection prevention department | 0.444396 |
| basic infection prevention | 0.440875 |
| mental health problems | 0.416784 |
| effective patient care | 0.379228 |
| patients | 0.325712 |
| patient care | 0.463655 |
| health care costs | 0.418101 |
| Unpasteurized Goat Milk | 0.362887 |
| traditional microscopy-based methods | 0.502129 |
| Ebola outbreaks | 0.568826 |
| patient safety protocols | 0.396031 |
| infection isolation precautions | 0.405267 |
| seed outbreaks | 0.342976 |
| CDC Media Relations | 0.958715 |
| physical assault-related injuries | 0.382315 |
|
| Local traditional leaders | 0.381888 |
| community members | 0.323575 |
| valuable medical resources | 0.36116 |
| basic telephone access | 0.367989 |
| community leaders | 0.321916 |
| infection control | 0.345877 |
| community factors | 0.322036 |
| Cepheid Xpert MTB/RIF | 0.52599 |
| Wisconsin Division | 0.312745 |
| valuable hospital resources | 0.367982 |
| community quarantine | 0.538862 |
| youth violence | 0.706245 |
| surgical patient care | 0.406998 |
| subsequent outbreaks | 0.343036 |
| public health | 0.695678 |
| remote areas | 0.385778 |
| Xpert MTB/RIF Assay | 0.824901 |
| New Jersey Department | 0.410374 |
| new Ebola cases | 0.472867 |
| significant public health | 0.421177 |
| community needs | 0.318582 |
| logistically difficult settings | 0.362142 |
| infection prevention | 0.471256 |
| public health problem | 0.544305 |
|
CLICK HERE |